ARCADIA PRECLINICAL PARTNERS LLC
Preclinical Drug Development Consulting
About Us
Bringing 23 years of industry leading experience, Arcadia Preclinical Partners LLC was founded in 2021 with the mission of providing our clients with expert and timely guidance for preclinical drug development programs. Beyond providing overall direction with respect to successful program development and implementation, we offer specialized services in key areas of safety evaluation. As a unique addition to traditional preclinical consulting services, Arcadia Preclinical Partners also offers educational guidance for technical staff and institutional trainers to help our Clients assure consistency in performance excellence as well as to incorporate new capabilities.
Meet the Partners
Services
Safety Evaluation Program Development and Oversight
-
Program Guidance
-
Gap Analysis
-
Protocol Development
-
Study Monitoring
-
Scientific Writing, Editing, and Review
Neurobehavioral Safety Assessment
-
Tier I and higher order CNS safety assessment
-
Drug Abuse and Dependence Liability
-
Sensory evaluations
Electrocardiography Assessment and Interpretation
-
Multi-species, preclinical
-
Qualitative Rhythm Assessment
-
Quantitative Interval Analysis
-
Toxicology and safety pharmacology study support
Business Unit Consulting
-
Safety Pharmacology and Toxicology
-
Assessment, strategic planning, implementation
-
Staff training and development
-
Professional referrals
Educational Services
-
Technical Staff training
-
Specialized education for trainers
-
Study Director and Study Monitor development
-
Key areas of expertise:
-
Cardiovascular and neurobehavioral assessments
-
Electrocardiography
-
Integrated study designs
-
Scientific data collection systems and processes
-
CONTACT US
222 N Kalamazoo Mall Suite 350, Kalamazoo, MI 49007, USA
269-303-1760